207 related articles for article (PubMed ID: 34043989)
21. The double-edged sword of AMPK signaling in cancer and its therapeutic implications.
Jeon SM; Hay N
Arch Pharm Res; 2015 Mar; 38(3):346-57. PubMed ID: 25575627
[TBL] [Abstract][Full Text] [Related]
22. Effects of AMPK on Apoptosis and Energy Metabolism of Gastric Smooth Muscle Cells in Rats with Diabetic Gastroparesis.
Zhang MH; Fang XS; Guo JY; Jin Z
Cell Biochem Biophys; 2019 Jun; 77(2):165-177. PubMed ID: 30968342
[TBL] [Abstract][Full Text] [Related]
23. Nootkatone, an AMPK activator derived from grapefruit, inhibits KRAS downstream pathway and sensitizes non-small-cell lung cancer A549 cells to adriamycin.
Hung LVM; Moon JY; Ryu JY; Cho SK
Phytomedicine; 2019 Oct; 63():153000. PubMed ID: 31280139
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of protein phosphatase 5 suppresses non-small cell lung cancer through AMP-activated kinase activation.
Hsieh FS; Hung MH; Wang CY; Chen YL; Hsiao YJ; Tsai MH; Li JR; Chen LJ; Shih CT; Chao TI; Chen KF
Lung Cancer; 2017 Oct; 112():81-89. PubMed ID: 29191605
[TBL] [Abstract][Full Text] [Related]
25. Intracellular signaling of the AMP-activated protein kinase.
Dërmaku-Sopjani M; Sopjani M
Adv Protein Chem Struct Biol; 2019; 116():171-207. PubMed ID: 31036291
[TBL] [Abstract][Full Text] [Related]
26. Thalidezine, a novel AMPK activator, eliminates apoptosis-resistant cancer cells through energy-mediated autophagic cell death.
Law BYK; Gordillo-Martínez F; Qu YQ; Zhang N; Xu SW; Coghi PS; Mok SWF; Guo J; Zhang W; Leung ELH; Fan XX; Wu AG; Chan WK; Yao XJ; Wang JR; Liu L; Wong VKW
Oncotarget; 2017 May; 8(18):30077-30091. PubMed ID: 28404910
[TBL] [Abstract][Full Text] [Related]
27. Targeting the 5'-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancer.
Popovics P; Frigo DE; Schally AV; Rick FG
Expert Opin Ther Targets; 2015 May; 19(5):617-32. PubMed ID: 25600663
[TBL] [Abstract][Full Text] [Related]
28. Negative regulation of the LKB1/AMPK pathway by ERK in human acute myeloid leukemia cells.
Kawashima I; Mitsumori T; Nozaki Y; Yamamoto T; Shobu-Sueki Y; Nakajima K; Kirito K
Exp Hematol; 2015 Jul; 43(7):524-33.e1. PubMed ID: 25846811
[TBL] [Abstract][Full Text] [Related]
29. IMPAD1 functions as mitochondrial electron transport inhibitor that prevents ROS production and promotes lung cancer metastasis through the AMPK-Notch1-HEY1 pathway.
Yang YF; Wang YY; Hsiao M; Lo S; Chang YC; Jan YH; Lai TC; Lee YC; Hsieh YC; Yuan SF
Cancer Lett; 2020 Aug; 485():27-37. PubMed ID: 32417395
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.
Zheng L; Yang W; Wu F; Wang C; Yu L; Tang L; Qiu B; Li Y; Guo L; Wu M; Feng G; Zou D; Wang H
Clin Cancer Res; 2013 Oct; 19(19):5372-80. PubMed ID: 23942093
[TBL] [Abstract][Full Text] [Related]
31. Role of AMP-activated protein kinase in cancer therapy.
Rehman G; Shehzad A; Khan AL; Hamayun M
Arch Pharm (Weinheim); 2014 Jul; 347(7):457-68. PubMed ID: 24677093
[TBL] [Abstract][Full Text] [Related]
32. Exopolysaccharides isolated from Rhizopus nigricans induced colon cancer cell apoptosis in vitro and in vivo via activating the AMPK pathway.
Lu Y; Zhang X; Wang J; Chen K
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894839
[TBL] [Abstract][Full Text] [Related]
33. LCAL1 enhances lung cancer survival via inhibiting AMPK-related antitumor functions.
Li JY; Luo ZQ
Mol Cell Biochem; 2019 Jul; 457(1-2):11-20. PubMed ID: 30741368
[TBL] [Abstract][Full Text] [Related]
34. AMPK signaling and its targeting in cancer progression and treatment.
Hsu CC; Peng D; Cai Z; Lin HK
Semin Cancer Biol; 2022 Oct; 85():52-68. PubMed ID: 33862221
[TBL] [Abstract][Full Text] [Related]
35. Targeting AMPK for cancer prevention and treatment.
Li W; Saud SM; Young MR; Chen G; Hua B
Oncotarget; 2015 Apr; 6(10):7365-78. PubMed ID: 25812084
[TBL] [Abstract][Full Text] [Related]
36. The PLAG1-GDH1 Axis Promotes Anoikis Resistance and Tumor Metastasis through CamKK2-AMPK Signaling in LKB1-Deficient Lung Cancer.
Jin L; Chun J; Pan C; Kumar A; Zhang G; Ha Y; Li D; Alesi GN; Kang Y; Zhou L; Yu WM; Magliocca KR; Khuri FR; Qu CK; Metallo C; Owonikoko TK; Kang S
Mol Cell; 2018 Jan; 69(1):87-99.e7. PubMed ID: 29249655
[TBL] [Abstract][Full Text] [Related]
37. Gene of the month. AMP kinase (PRKAA1).
Krishan S; Richardson DR; Sahni S
J Clin Pathol; 2014 Sep; 67(9):758-63. PubMed ID: 24895169
[TBL] [Abstract][Full Text] [Related]
38. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways.
Wang Y; Xu W; Yan Z; Zhao W; Mi J; Li J; Yan H
J Exp Clin Cancer Res; 2018 Mar; 37(1):63. PubMed ID: 29554968
[TBL] [Abstract][Full Text] [Related]
39. Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer: a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation.
Chang WL; Hsu LC; Leu WJ; Chen CS; Guh JH
Oncotarget; 2015 Nov; 6(37):39806-20. PubMed ID: 26447757
[TBL] [Abstract][Full Text] [Related]
40. Targeting AMPK Signaling Pathway to Overcome Drug Resistance for Cancer Therapy.
Wang Z; Liu P; Chen Q; Deng S; Liu X; Situ H; Zhong S; Hann S; Lin Y
Curr Drug Targets; 2016; 17(8):853-64. PubMed ID: 25777274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
